Under the new manager, expectations were high that the team would adopt a more attacking style of play and showcase greater tactical flexibility. However, what has transpired on the pitch has been far from inspiring. Manchester United has struggled to find its rhythm, and performances have been lackluster at best. The team has lacked cohesion and creativity, leading to a string of poor results and an alarming drop in the league standings.
As the storm approaches and weather conditions deteriorate, staying informed through local news sources, weather alerts, and official announcements is key to staying safe and informed. Following the guidance of emergency officials and heeding evacuation orders, if necessary, can help reduce the risk of injury or harm during a blizzard.
As social media platforms like TikTok, Instagram, and Twitter became inundated with posts and memes about 'Sleepgate', more and more young people were drawn to the concept. The allure of spending lazy mornings in bed, binge-watching TV shows, scrolling through social media feeds, and enjoying breakfast in bed appealed to a generation grappling with the pressures of work, school, and social obligations.German auto technology supplier... The Associated Press
The team that President-elect Donald Trump has selected to lead federal health agencies in his second administration includes a retired congressman, a surgeon and a former talk-show host. All could play pivotal roles in fulfilling a political agenda that could change how the government goes about safeguarding Americans' health — from health care and medicines to food safety and science research. In line to lead the Department of Health and Human Services secretary is environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr. Trump's choices don't have experience running large bureaucratic agencies, but they know how to talk about health on TV . People are also reading... Centers for Medicare and Medicaid pick Dr. Mehmet Oz hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. Marty Makary, and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump's other Cabinet nominees: Dave Weldon , the pick for the Centers for Disease Control and Prevention, represented the state in Congress for 14 years and is affiliated with a medical group on the state's Atlantic coast. Nesheiwat's brother-in-law is Rep. Mike Waltz , R-Fla., tapped by Trump as national security adviser. Here's a look at the nominees' potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 trillion budget, employ 80,000 scientists, researchers, doctors and other officials, and effect Americans' daily lives: The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is "no vaccine that is safe and effective,” and urged people to resist the CDC's guidelines about if and when kids should get vaccinated . The World Health Organization estimates that vaccines have saved more than 150 million lives over the past 50 years, and that 100 million of them were infants. Decades ago, Kennedy found common ground with Weldon , 71, who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon's congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products, as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on several topics . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he'll clear out “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, raw milk , psychedelics and discredited COVID-era treatments like ivermectin and hydroxychloroquine. Makary's contrarian views during the COVID-19 pandemic included questioning the need for masking and giving young kids COVID-19 vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn't talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though they're not widely covered by either . Trump said during his campaign that he would protect Medicare, which provides insurance for older Americans. Oz has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular but also a source of widespread fraud — in an AARP questionnaire during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a 2020 Forbes op-ed with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner op-ed with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump's first administration reshaped the program by allowing states to introduce work requirements for recipients. Kennedy doesn't appear to have said much publicly about what he'd like to see from surgeon general position, which is the nation's top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, declared gun violence as a public health crisis in June. Trump's pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the Women in Medicine Legacy Foundation , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he'd pause drug development and infectious disease research to shift the focus to chronic diseases. He'd like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — an idea that has long been debunked . Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. This story has been corrected to reflect that the health agencies have an overall budget of about $1.7 trillion, not $1.7 billion. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Sign up here to get the latest health & fitness updates in your inbox every week!The man, whose identity remains undisclosed, was a trusted employee at a prominent company, where he held a high-ranking position. However, fueled by his insatiable desire for recognition and status, he began siphoning off large sums of money from the company's accounts over a period of several months. His elaborate scheme involved falsifying financial records and covering his tracks to avoid detection.
The Philippine Institute of Volcanology and Seismology (PHIVOLCS) raised the alert level to 4, indicating that a hazardous eruption is imminent. This has led to the evacuation of thousands of residents living within a 14-kilometer radius of the volcano. Authorities have set up evacuation centers to accommodate those displaced by the eruption and have urged residents to follow safety protocols to prevent any casualties.When we talk about "moderate easing," we are referring to a set of measures aimed at loosening monetary policies in a controlled and gradual manner. This can take various forms, such as lowering interest rates, increasing government spending, or implementing quantitative easing programs. The goal of moderate easing is to provide a boost to the economy without causing excessive inflation or creating financial instability.
The power of emotional value can be seen in various other areas as well, such as the art market. Paintings and sculptures by famous artists can fetch millions of dollars due to the emotional response they evoke in viewers. Similarly, memorabilia from historical events or iconic figures can command high prices due to the emotional connections they represent.MG has a storied history, and in recent years it has established a strong presence in the Australian market, primarily by selling cheap cars with mass-market appeal. It’s currently ranked seventh in Australia’s new-vehicle sales chart, and while it isn’t on track to surpass its 2023 sales record, it’s still a top contender with an ever-expanding local model lineup. Know the news with the 7NEWS app: Download today MG’s model range is being bolstered by the arrival of new and upgraded vehicles across a variety of market segments, which are serving to help the brand elevate itself up and away from its cheap-and-cheerful roots roots. Indubitably, it’s cheap cars like the MG 3 hatch that come to mind when MG is mentioned, though the all-new MG 4 electric hatch, the long-awaited new MG 3 and subsequent renewals of other models like the HS mid-sized SUV and ZS small SUV are helping to shift perceptions – as is the arrival of the $100,000-plus Cyberster electric sports car. But MG as we know it now is just its latest iteration, and there’s a lot more to the brand name than what’s happened in only the past 15 years. Most car enthusiasts and anyone middle-aged won’t be surprised to read MG was originally an entirely British manufacturer most notable for small sports cars loaded with charm. But did you know the MG name came from modifying another company’s vehicles? Or that the brand established its historical sporting pedigree through motorsport success as long ago as the 1930s? Here we’ll break all that down, including the factors that led to its eventual downfall in the early 2000s and its subsequent rebirth as a global automotive powerhouse under Chinese ownership. As the marque celebrates its 100th birthday, here’s everything you need to know about MG. Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG What is MG? MG – specifically MG Motor – is headquartered in Shanghai, China, and has been owned by the Chinese state-owned carmaker SAIC Motor since 2007. Many will know the MG badge for its much older origins though, and there’s plenty to unpack from its 100-year history. MG was established in 1924, when the first vehicles created by British car designer Cecil Kimber appeared in Oxford. Its origins aren’t as clear cut as other carmakers though, because the brand effectively began as an unofficial spin-off of Morris Garages – owned by British motor manufacturer William Morris. Morris Garages was an automobile retail sales and service centre in Oxford, where Mr Kimber was hired as a sales manager in 1921 and promoted to general manager in 1922. He went on to become the founder of MG. He began by modifying the standard production Morris Oxford, a model that had been in production since 1913. Mr Kimber’s modified versions were dubbed Kimber Specials, and they featured both Morris and MG badges. A reference to MG with its iconic octagon badge first appeared in a local newspaper in late 1923, and the symbol was later registered as a trademark by Morris Garages in 1924. In the same year, the MG 14/28 appeared as the company’s first recognised model, and in 1925 the MG Old Number One went on sale. Continued expansion over the coming years led to Morris Garages moving to several new locations, until a facility near the main Morris factory in Cowley, Oxford became its home in 1927. That factory provided the company its first opportunity to employ an actual production line. MG continued to grow and by 1928 it was large enough to warrant the establishment of an identity separate to the original Morris Garages, and so it was subsequently dubbed the M.G. Car Company in March 1928 – a name derived from its origins. 1928 also saw the launch of the first MG model that wasn’t a modified Morris, the MG 18/80. In October of that year it hosted its first exhibit at the London Motor Show, followed by another necessary relocation to a larger factory in Abingdon, Oxfordshire in 1929. In that year, it launched the first in a long line of its iconic sporty Midgets, the Morris-derived M-Type. The official M.G. Car Company was incorporated on July 21, 1930. It soon rolled out several small T-Series models that were later exported worldwide following World War II. Those cars achieved unexpectedly high success thanks to models like the MG TC, TD, and TF – all of which were based on the pre-war MG TB. Throughout the 1930s, MG also began enjoying success in motorsport after toppling British giants like Bentley. Mr Kimber stayed with the company as its managing director until 1935, when Mr Morris – who was still the company’s main shareholder – formally sold the M.G. Car Company to Morris Motors, which meant Mr Kimber was no longer the sole controlling owner. In the coming years the outbreak of WWII halted car production at MG, but it continued making basic items for the British army until Mr Kimber controversially obtained a contract to work on aircraft. He did so without prior approval, which led to company executives asking him to resign. He left in 1941 and soon found work elsewhere, though he was tragically killed in a railway accident at London’s King’s Cross station in 1945. In 1952, the M.G. Car Company and Morris were absorbed into the British Motor Corporation (BMC), which was created through a merger between Morris Motors and the Austin Motor Company. MG soon departed from its earlier pre-war designs to release the MGA in 1955. It was later followed by the iconic MGB in 1962, in response to demand for a more modern and comfortable sports car. From 1967 to 1969 a short-lived MGC was produced, which was based on the MGB but featured a larger, heavier six-cylinder engine and noticeably worse handling. Aside from those small sports cars though, many of MG’s cars under BMC were simply badge-engineered versions of models from other marques. One such car was the MG Midget of 1961, which was a rebadged and slightly restyled Austin-Healey Sprite. In 1966, BMC merged with Jaguar Cars to form British Motor Holdings (BMH), which itself merged with the Leyland Motor Corporation in 1968 to form the British Leyland Motor Corporation (BLMC). From the early 1970s under BLMC, the M.G. Car Company name disappeared and the MG marque began to only be used for rebadged models from BLMC’s other brands. The exception was the unsuccessful MGB GT V8, which was only in production from 1973 to 1976. While both the MGB and Midget designs were frequently modified to keep up to date with changing safety regulations, primarily in the United States, those two popular models were becoming outdated under BLMC ownership. MG’s step back during this period was largely caused by BLMC, later British Leyland, whose management and engineering staff were predominantly carried over from the former Leyland organisation. That was unfortunate for MG, as the Leyland company previously incorporated Triumph – its historically close rival. In fact, while Triumph was able to release new models during the 1970s like the TR7 and Dolomite, no new MG models were introduced except for that short-lived V8 MGB. Several distinct tiers emerged at British Leyland, with Triumph, Rover and Jaguar bundled into its Specialist Division, while MG was placed in the Austin-Morris division that generally made mass-produced family cars. Despite its lower status, MG proved to be profitable, though its profits were offset by substantial losses mounting from the rest of the Austin-Morris division. That meant any funding allocated to the division by British Leyland was diverted away from MG and instead to desperately needed mass-market models. That left MG with limited funding to maintain its tired lineup, let alone develop new models. The Abingdon plant closed as a result (bringing with it the death of the MGB and Midget), and in the 1980s MG returned to being used for badge-engineering Austin Rover models like the Metro, Maestro, and Montego. It wasn’t until 1992 that the MG marque reappeared in its own right, with the MG RV8 – an updated MGB Roadster with a V8 engine from Rover – previewed at that year’s Birmingham Motor Show. It entered low-volume production in 1993. That car was followed by the MG F in 1995, which was the first mass-produced all-new MG sports car since the death of the MGB in 1980. By that point, MG ownership had shifted hands multiple times. British Leyland became the Rover Group in 1986, which led to the MG marque being passed to British Aerospace in 1988 and then BMW in 1994. BMW sold the business in 2000, when the MG marque was passed on to the MG Rover Group based at the historic car factory in Longbridge, Birmingham. MG’s own sports cars continued to be sold alongside rebadged Rovers, and the lineup included the models like the MG ZS small sedan (a rebadged Rover 45) and the Rover 75 mid-sized sedan, both of which were sold in Australia in the mid-2000s. In 2005, the overarching MG Rover Group entered administration with £1.4 billion (~A$2.7 billion) in debt, and car production was suspended on April 7, 2005. Interestingly, the group wasn’t formally dissolved until May 2023. China had entered the MG picture as early as 2004, when reports of a joint venture between SAIC and MG Rover led to speculation from British media that a takeover was imminent. That initial venture fell through, and SAIC denied it had tried to purchase the company. In July 22, 2005, Nanjing Automobile Group purchased the rights to MG along with the MG Rover Group’s other assets, but it couldn’t acquire the Rover name from BMW and thus created Roewe. The company formed was titled NAC MG UK, and Nanjing Automobile later merged with SAIC Motor in 2007. Earlier in 2007 though, Nanjing had restarted MG production, which saw sports cars like the MG TF manufactured at Longbridge from 2008 to 2010. The company was renamed to MG Motor UK in 2009, and MG continues to be controlled by SAIC to this day. The first all-new MG in 16 years hit the market in the form of the MG 6 in 2011 – though it was derived from the SAIC-owned Roewe 550 and was thus distantly related to the Rover 75, which ended production in 2005. It was built both in China and in the United Kingdom at Longbridge, and was followed by the MG 3 in 2013. MG Motor ended production at the Longbridge plant in September 2016. MG vehicles have been primarily built in China ever since – with the exception of localised operations in countries like Thailand and India. SAIC has since designated MG as its main international brand, and it became China’s largest single-marque car exporter in 2019. MG Motor went on to sell around 840,000 units globally in 2023, when 88 per cent of its sales were outside of China. Apart from of SAIC-developed MG models, MG Motor also sells rebadged versions of other vehicles from SAIC-owned brands like Roewe (successor to Rover) and Maxus (founded by SAIC in 2011). One such vehicle is the second-generation MG HS, which is a rebadged version of the Chinese-market Roewe RX5. The new HS was released in 2024, alongside new-generation versions of the MG 3 and ZS, replacing Australia’s top-selling light car and small SUV, respectively. MG Motor has also since released its first roadster under Chinese ownership, the battery-electric Cyberster. Between 2020 and 2023, MG was one of the fastest-growing brands in the UK and Europe, and during the same period its Australian sales quadrupled. Its most popular global model continues to be the ZS, while MG’s sales were boosted by the arrival of its first electric vehicle (EV) developed from the ground up – the MG 4 in 2022. In 2023, China was MG Motor’s largest market with 99,441 sales. It was followed by the UK with 81,289, Mexico with 60,128, and Australia with 58,346. Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG What can you currently buy from MG? MG currently sells six distinct models in Australia, though there are several caveats. MG’s Australian lineup is as follows: Prices are based on a Victorian postcode, and all exclude on-road costs unless specified as drive-away (D/A). You can click the names of the cars in the table above to be taken to their dedicated CarExpert showrooms. Prices for the MG 3, 4, and 5 are all as-listed, though specific drive-away pricing for the MG 4 range is only listed for the base-spec Excite 51. It’s also worth noting there are currently several factory bonus deals available, which bring discounts for models like the ZS EV – check MG’s website for more details. There are also several ZS models, which can be explained as standard (ZS), updated and restyled (ZST), electric (ZS EV), and new-generation (ZS Hybrid+) – the latter of which is hitting showrooms this month and will be followed by new petrol versions early next year. The HS and 3 are now officially in their second-generation guises, while the all-new Cyberster has only just arrived in Australia and will go on sale next month. While the HS and 3 are two models that received significant updates this year, you can still purchase new previous-generation versions of both models while stocks last. The old MG 3 is currently discounted through MG’s run-out sale for $19,990 drive-away, alongside the old HS for either $28,990 drive-away or $30,990 drive-away depending on the variant. Similarly, the outgoing HS Plus EV plug-in hybrid is on sale for either $34,990 drive-away or $37,990 drive-away. We’ll now provide a top-line overview of each of the new and incoming models, though it’s worth checking out our individual price and specs articles for detailed information. These will be linked to the model’s name below. The MG 3 is the brand’s smallest model, and it’s available as either a standard petrol variant or the electrified Hybrid+. Each employ a 1.5-litre four-cylinder engine, and non-hybrids get a continuously variable transmission (CVT) compared to the ‘hybrid’ transmission in the Hybrid+. Drive is sent to the front wheels only. It’s a similar story with the MG 5 , though its higher-spec version adds a turbocharger and a dual-clutch transmission to its 1.5-litre four-cylinder petrol engine. Lower grades utilise a CVT, and all are front-wheel drive. A facelift for the MG 5 has been revealed in China, and it’ll likely arrive in Australia early next year. As for MG’s SUVs, there are currently two in the lineup. The smallest of the pair is the ZS, which has been on sale for some time and has just been released in next-generation Hybrid+ form. The outgoing ZS only has one variant available, which utilises a 1.5-litre four-cylinder engine and a four-speed torque converter transmission. It’s front-wheel drive only. Above that is the ZST , which is updated and restyled compared to the standard ZS. It’s front-wheel drive only and there are four variants; the bottom two use a 1.5-litre four-cylinder mated with a CVT, while the top two gain a 1.3-litre turbo three-cylinder and a six-speed torque converter automatic. The new-gen ZS Hybrid+ is arriving this month in two variants, both with a 1.5-litre four-cylinder engine. That’s mated with a three-speed motor-assisted hybrid transmission, with drive again sent to the front wheels only. There’s also the larger HS , which is now in its second generation. It’s sold in three variants, and all use a 1.5-litre turbo four-cylinder mated with a seven-speed dual-clutch automatic. MG’s EV range also includes SUVs with the ZS EV , which is sold in three variants. The two cheapest variants utilise a 50.3kWh battery pack for 320km of WLTP range, while the top-spec Long Range gains a 72kWh unit for a claimed range of 440km. Then there’s the dedicated-electric MG 4 , Australia’s cheapest EV, that is sold in five variants. The base Excite 51 is the only one to use a 51kWh battery for a claimed range of 350km, while the next two up use a 64kWh battery for ranges of 450km and 435km respectively. The Long Range 77 has a 77kWh battery pack and a claimed range of 530km, and all are rear-wheel drive. The odd one out is the XPower at the top of the range, which has a dual-motor all-wheel drive setup, a 64kWh battery, and 400km of driving range. Finally, MG Motor’s most unique global car to date is the all-electric Cyberster . It’s coming to Australia in one all-wheel drive variant, and it’s the most expensive car MG has ever brought here. The scissor-door convertible utilises a 77kWh battery pack for a claimed range of 443km, while MG says it can reach 0-100km/h in just 3.2 seconds. Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG Which brands does MG compete against? MG is primarily competing against auto brands that sell similarly affordable cars in Australia, namely Chery, GWM, Suzuki, Mitsubishi, and – at a stretch – Mazda. Firstly Chery, as it’s another Chinese brand competing in similar Australian market segments. Its Omoda 5 and Tiggo 4 Pro are strong rivals for the ZST and ZS respectively, largely due to their price and size. The entry-level Omoda 5 FX is priced at $27,990 drive-away, compared to the ZST Core’s $26,990 drive-away price tag. On the cheaper end, the Tiggo 4 Pro costs as little as $23,990 drive-away, while the ZS is priced from $20,990 drive-away. In terms of larger SUVs, the closest matched vehicles are the Chery Tiggo 7 Pro ($39,990 drive-away) and the MG HS ($34,990 drive-away). GWM – another Chinese manufacturer – competes against MG’s SUVs with its Haval-branded Jolion and H6 models, while the Ora EV is also a strong rival for the MG 4. The MG 3 is MG’s cheapest and smallest car, therefore making it a rival for the Suzuki Swift Hybrid . There are some differences though – the MG 3 is cheaper than the Swift Hybrid, and the cheapest Swift Hybrid offers a manual transmission instead of a CVT. Mitsubishi’s ASX small SUV goes up against the ZS on price in particular, while its larger models like the Eclipse Cross and Outlander can also be compared to the HS in size and price – though the HS wins out on standard tech. Mazda isn’t a direct rival for MG, though its smaller and older models like the Mazda 2 and CX-3 would likely be cross-shopped against the MG 3 (MG 5 in sedan guise) and ZS respectively. The key difference is Mazda’s cheapest models tend to offer a slightly higher level of luxury (albeit without being legitimately luxurious) than comparable MGs. Similarly, the Cyberster doesn’t currently have any direct competitors, given its unique positioning as an all-electric high-performance roadster. Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG How popular is MG in Australia? MG is currently Australia’s seventh-best selling auto brand, sandwiched between Mitsubishi in sixth and Isuzu in eighth. Against the above rivals on yearly sales to the end of October this year, MG (41,302) ranks considerably higher than both Chery (8956) and Suzuki (17,670), though there’s a much smaller gap to GWM (35,143). It’s still well behind Mazda (81,143) and Mitsubishi (62,588), the latter of which is currently enjoying a year-to-date sales increase of a sizeable 20.1 per cent. MG, meanwhile, is currently down 15.6 per cent on its figure from this time last year. That means MG is on track to fall short of its record sales figure of 58,346 in 2023, if it maintains October’s monthly sales of 5206 for the rest of the year. It is, however, only around 8000 units down on its 2022 sales figure of 49,582. MG remains Australia’s top-selling Chinese brand, with GWM currently its closest rival on the charts. The brand’s best-selling model here is the ZS, which has found 18,668 new homes so far this year. It’s worth noting that figure combines sales of the ZS, ZST, and ZS EV. It’s followed by the MG 3 on 10,421, but after that is a sizeable gap to the MG 4, its second most popular model with 5258 sales. Making up the rest of the total are the HS and MG 5 with 3530 and 3425 sales respectively. Interestingly, both the ZS and MG 4 made the sales top 20 for the month of October this year. The ZS ranked 11th, ahead of cars like the Toyota Corolla and Mazda CX-3 , while the MG 4 was 16th and ahead of the Isuzu MU-X and Hyundai i30 . Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG What’s next for MG? MG has multiple new models on the way in 2025 alone, following the launch of several others in late 2024. The two recently launched new models are the Cyberster and the ZS Hybrid+ , which will be on sale shortly. The next new MG expected to arrive here is the MG 7 fastback , which entered production in China in 2022. It’ll fill the large sedan space currently unoccupied by MG, whose only current sedan is the smaller MG 5. On that note, an update to the MG 5 is expected to arrive at a similar time to the MG 7, and it’s expected to improve the current model’s ANCAP safety rating. Next up is the new petrol-powered ZS , which is expected to arrive in the first half of 2025. Though it follows the Hybrid+ version, it’ll feature the same design and bring the rest of the ZS range into the current generation. Similarly, a replacement for the ZS EV is expected to arrive in first half of next year – though it’ll likely look different to the new ZS and more like the S5 electric SUV spied in Australia earlier this year. Unlike the MG 3-based ZS, the S5 will share its platform with the MG 4. Another MG 4-influenced car is the second-generation Marvel R , which is another electric SUV but appears to be closer in size to the HS. The current Marvel R has been sold overseas for some time, but never in Australia. The second-generation version is expected to arrive in local showrooms in the first half of 2025. As MG’s largest SUV, however, the HS is expected to gain hybrid and plug-in hybrid versions in mid-2025. They’ll join the latest petrol HS, which itself arrived in Australia earlier this year. MG is also looking to bring its first seven-seat SUV to Australia in the future, and – like the HS – it’s expected to be a rebadged SUV from fellow SAIC brand Roewe. In this case it’ll be the RX9, but timing is unconfirmed. While MG has confirmed the RX9 for the Philippines, it may need a different name in Australia given Mazda owns the rights to the RX-9 trademark here. Interested in an MG? CarExpert’s specialists can help get you in touch with a dealer . MORE: Everything MG
In conclusion, the drone crash during Cai Guoqiang's performance serves as a cautionary tale about the unpredictable nature of technology and the importance of handling it with care and responsibility. Let us remember to appreciate the artistry and skill behind such performances while also recognizing the risks involved and the need for vigilance and caution in the pursuit of creative expression.President Joe Biden on Monday signed into law a defense bill that authorizes significant pay raises for junior enlisted service members, aims to counter China 's growing power and boosts overall military spending to $895 billion despite his objections to language stripping coverage of transgender medical treatments for children in military families. Biden said his administration strongly opposes the provision because it targets a group based on gender identity and "interferes with parents’ roles to determine the best care for their children.” He said it also undermines the all-volunteer military's ability to recruit and retain talent. “No service member should have to decide between their family’s health care access and their call to serve our nation,” the president said in a statement. The Senate forwarded the bill to Biden after passing it last week by a vote of 85-14. In the House, a majority of Democrats voted against the bill after House Speaker Mike Johnson insisted on adding the provision to ban transgender medical care for children. The legislation easily passed by a vote of 281-140. Biden also objected to other language in the bill prohibiting the use of money earmarked to transfer detainees held at Guantanamo Bay, Cuba , to some foreign countries and into the United States. He urged Congress to lift those restrictions. The annual defense authorization bill, which directs Pentagon policy, provides a 14.5% pay raise for junior enlisted service members and a 4.5% increase for others. The legislation also directs resources towards a more confrontational approach to China, including establishing a fund that could be used to send military resources to Taiwan in much the same way that the U.S. has backed Ukraine. It also invests in new military technologies, including artificial intelligence, and bolsters the U.S. production of ammunition. The U.S. has also moved in recent years to ban the military from purchasing Chinese products, and the defense bill extended that with prohibitions on Chinese goods from garlic in military commissaries to drone technology. The legislation still must be backed up with a spending package. __ Associated Press writer Stephen Groves contributed to this report.
Jayden Daniels dazzles again as Commanders clinch a playoff spot by beating Falcons 30-24 in OTSAN DIEGO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued in connection with the Company's initial public offering ("IPO"). Kyverna is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTX) Provided Investors with Misleading Information in Connection with its IPO According to the complaint, the Offering Documents in support of Kyverna's IPO were negligently prepared and were not prepared in accordance with the rules and regulations governing their preparation. The complaint alleges that the Offering Documents stated, “[i]n early results available as of December 31, 2023, from the first two adult patients enrolled in our KYSA-1 LN trial and from the first adult patient enrolled in our KYSA-3 LN trial, we observed improvement in UPCR.” However, Plaintiff contends this statement, and others, was false and misleading because Kyverna failed to disclose adverse data it possessed related to one of its trials. By the commencement of this action, Kyverna’s shares traded as low as $3.92 per share, a decline of more than 82% from the Offering Price. What Now: You may be eligible to participate in the class action against Kyverna Therapeutics, Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by February 7, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Kyverna Therapeutics, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b9c000ea-96b0-4098-b8fa-c12bc6c2d356Across the recent three months, 9 analysts have shared their insights on Endava DAVA , expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 2 2 0 0 Last 30D 0 0 1 0 0 1M Ago 3 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 2 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $38.67, a high estimate of $55.00, and a low estimate of $27.00. A decline of 10.86% from the prior average price target is evident in the current average. Breaking Down Analyst Ratings: A Detailed Examination A comprehensive examination of how financial experts perceive Endava is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Tyler DuPont B of A Securities Announces Neutral $29.00 - Mayank Tandon Needham Raises Buy $36.00 $33.00 Bryan Bergin TD Cowen Raises Buy $36.00 $35.00 Jonathan Lee Guggenheim Lowers Buy $40.00 $45.00 Ashwin Shirvaikar Citigroup Lowers Neutral $27.00 $30.00 James Friedman Susquehanna Lowers Positive $55.00 $66.00 Mayank Tandon Needham Lowers Buy $33.00 $42.00 Jonathan Lee Guggenheim Lowers Buy $45.00 $55.00 Puneet Jain JP Morgan Raises Overweight $47.00 $41.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Endava. This information provides a snapshot of how analysts perceive the current state of the company. Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Endava compared to the broader market. Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Endava's stock. This comparison reveals trends in analysts' expectations over time. To gain a panoramic view of Endava's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table. Stay up to date on Endava analyst ratings. If you are interested in following small-cap stock news and performance you can start by tracking it here . Discovering Endava: A Closer Look Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries. Unraveling the Financial Story of Endava Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity. Revenue Growth: Endava's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 3.52% . This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers. Net Margin: Endava's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.15%, the company may face hurdles in effective cost management. Return on Equity (ROE): Endava's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.36%, the company may face hurdles in generating optimal returns for shareholders. Return on Assets (ROA): Endava's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial returns. Debt Management: Endava's debt-to-equity ratio is below the industry average at 0.3 , reflecting a lower dependency on debt financing and a more conservative financial approach. Analyst Ratings: Simplified Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are. Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update. Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability. Which Stocks Are Analysts Recommending Now? Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The motive behind the shooting remains unclear, but sources close to the investigation suggest that the suspect and Smith had a history of conflict and disagreement over the direction of the company. It is believed that the suspect took extreme measures to make a statement and assert his beliefs, resulting in a tragic loss of life and a devastating impact on the healthcare industry.PARIS, Dec 24 — Beloved British animated couple Wallace and Gromit are returning to screens in their first feature-length film in 20 years for a typically mad-cap adventure that spotlights the dangers of technology in the wrong hands. Vengeance Most Fowl will air on the BBC on Christmas Day for the first time before being made available on the Netflix platform from January 3 worldwide. Inventor and director Nick Park has returned to the technology theme that he explored in his 1993 Oscar-winning hit The Wrong Trousers , but updated to take into account the advent of artificial intelligence (AI). The tale centres on tea and cheese-loving Wallace’s latest invention: an “intelligent” robotic gnome called Norbot, which helps around the house and garden, threatening to replace the ever-loyal Gromit, who takes pride in the daily tasks of life. “Wallace is completely deluded and obsessed, whereas Gromit represents the human touch,” Park told AFP in a pre-release interview. “He likes doing his gardening. It’s not about just seeing an end result, it’s the act of doing that is enjoyable. “I love the fact that we have technology. We have to just sometimes ask: is it always enhancing our lives and our relationships, or is it somehow diminishing them in some way?” ‘Real humans’ Park has shown loyalty to the idea of “doing” throughout his four-decade career and still insists on real-world modelling to create Wallace and Gromit instead of resorting to computerised imagery. At his Aardman Animations studio — makers of other hits including Chicken Run and Shaun the Sheep — films are shot frame-by-frame, with clay models slowly moved and altered in a technique known as “stop motion” that dates back to the dawn of cinema. At their fastest rate, the 200-person production team for Vengeance Most Fowl produced two minutes of film per week. “Everything’s made by real human beings and that hopefully shines off the screen,” Park said. The limitations actually spur creativity, he insists, and are a core part of the franchise’s appeal. “With CGI (computer-generated imagery) I guess you are tempted to just use it to the full. You’ve got everything at your disposal,” he said. “Whereas I think if you don’t have that, you tend to be more creative with what little you’ve got.” The film sees the return of the villainous penguin Feathers McGraw from The Wrong Trousers , which won an Oscar for best short animated film. Feathers McGraw is blank-faced throughout, but his on-screen menace is always obvious — often to comical effect — while a full range of emotions are expressed, as ever, through the legendary eyebrows of Gromit. “Very small nuanced movements can say a lot,” Park said. One small change to listen out for in the new film is Wallace’s new voice after the death of English actor Peter Sallis, who had played him since his debut in 1989. Sallis has been replaced by Ben Whitehead, an English voice artist and actor who collaborated with Park on the last full-length Wallace and Gromit film, The Curse of the Were-Rabbit , released in 2005. — AFP
Since leaving Barcelona for Paris Saint-Germain in a world-record transfer back in 2017, Neymar's turbulent journey has been marked by a series of highs and lows. While he has enjoyed success and accolades with PSG, including domestic titles and individual awards, the magnetic pull of Barcelona has always lingered in his heart. The prospect of reuniting with Lionel Messi and leading the Blaugrana to glory once again remains a tantalizing dream for the mercurial forward.The decision to transition to a 5-hour workday is based on extensive research and consultation with our team members. Studies have shown that shorter work hours can actually boost productivity and employee satisfaction, as it allows for better work-life balance and reduces burnout. By streamlining our employees' schedules and ensuring they are well-rested and motivated, we believe that we can provide faster and more efficient service to our customers.
( MENAFN - Investor Brand Network) Podfest expo , the premier international conference for podcasters, authors, video and other content creators, has announced details for its 11th annual event set to take place at the Renaissance Orlando at SeaWorld® from Jan. 16-19, 2025. The world's longest-running in-person podcasting conference, the event continues to lead the industry in education, innovation and community-building. Expecting over 2,000 independent creators, established voices and industry professionals, the expo will feature a full exhibit hall with cutting-edge technologies, services and tools designed to empower podcasters. All aspects of podcasting will be on display-from creation and technology to audience growth, monetization and video integration. To view the full press release, visit About Podfest Expo Since its inception in 2013, Podfest Expo has fostered a close-knit community of creators passionate about sharing their stories and expanding their reach. Scheduled meet-and-greets, private events, and networking socials throughout the four days will provide valuable opportunities to form partnerships and connections. For more details about the event, visit . About Web3MediaWire Web3MediaWire (“W3MW”) is a specialized communications platform with a focus on the next generation of internet technologies. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, W3MW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, W3MW brings its clients unparalleled recognition and brand awareness. W3MW is where breaking news, insightful content and actionable information converge. To receive SMS alerts from Web3MediaWire, text“Web3” to 888-902-4192 (U.S. Mobile Phones Only) For more information, please visit Please see full terms of use and disclaimers on the Web3MediaWire website applicable to all content provided by W3MW, wherever published or re-published: /Disclaimer Web3MediaWire Los Angeles, CA 310.299.1717 Office [email protected] Web3MediaWire is powered by IBN MENAFN23122024000224011066ID1109025676 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.